Study finds Mounjaro outperforms Ozempic in weight loss

Study finds Mounjaro outperforms Ozempic in weight loss

If you struggle with obesity, you’ve undoubtedly already heard all of the suggestions for losing weight. 

Of course, eating a healthy diet and exercising are important. However, will those actions be sufficient to assist obese individuals in reaching a healthy weight and reducing their risk of developing other chronic illnesses like diabetes, heart disease, and fatty liver disease? Most likely not.

However, some effective weight loss medications provided by the community pharmacy in Houston can help you out. One such name is Tirzepatide, sold under the brand name Mounjaro injection for type 2 diabetes, which has also been approved by the FDA as a diabetic medication for weight loss called Zepbound.

Ozempic has become a best-selling drug due to its ability to help people lose weight. However, according to a different analysis, Mounjaro, a different type 2 diabetes treatment option, seems to be much more successful at helping people lose weight.

Let’s find out more about the research and growing numbers about the Mounjaro for weight loss. 


What is Mounjaro & How Does it Work? 

Mounjaro (generic name tirzepatide) is an injectable treatment for Type 2 diabetes. It is only available on prescription.

Mounjaro injection functions by focusing on two hormones:

  • GLP-1 is a hormone released by your digestive tract that lowers blood sugar and promotes a sense of fullness.
  • Glucose-dependent insulinotropic polypeptide, a hormone that causes the secretion of insulin.


Tirzepatide, the active component of Mounjaro injection, functions similarly to semaglutide, the active component of Ozempic and Wegovy. 

However, tirzepatide not only decreases appetite but also mimics GIP, a second hormone that may enhance the body’s ability to break down sugar and fat.

Is Mounjaro for weight loss really effective? Let’s find what research has to convey. 

Researchers discovered that those taking tripeptide, the active ingredient in Mounjaro injection, had up to three times the likelihood of losing weight compared to those taking semaglutide, the active component in Ozempic and Wegovy. 


The results are based on actual data from over 18,000 adult Americans with obesity or overweight conditions who began using Mounjaro or Ozempic between May 2022 and September 2023.

The analysis revealed that patients on Mounjaro had a three times higher chance of losing 15% of their body weight and more than 2.5 times the chance of losing 10% of their body weight compared to those on Ozempic or Wegovy.


At the 3,6and 12-month points in the treatment, they also saw more significant weight reductions. In October 2023, additional research revealed that tirzepatide might be a better option than semaglutide for both blood sugar regulation and weight loss.

Patients on Mounjaro lost 5.9% of their body weight at three months, compared to 3.6% for those on Ozempic. Patients using Ozempic lost 5.9% of their body weight at six months, compared to 10.1% for those taking Mounjaro injection. After a year, Mounjaro respondents lost 15.2% of their body weight, whereas Ozempic participants lost 7.9%.

Additionally, patients without Type 2 diabetes lost more weight than those who had the illness, according to Truveta Research. 

What are the Mounjaro’s Side-Effects & Risks?

As with any drug, there are always adverse effects to take into account. Mounjaro’s side effects and risks have been the subject of much discussion and can include:

  • Vomiting
  • Nausea
  • Abdominal pain
  • Constipation 
  • Diarrhea

Mounjaro and Ozempic cause gastrointestinal side effects and problems with fat digestion because they both slow down digestion and lower stomach acid. Mounjaro for weight loss additionally comes with a small (less than 1%) risk of serious adverse reactions such as pancreatitis or gallbladder disease, as well as thyroid C-cell tumours. 

“Tirzapetide is already associated with risks to the thyroid, pancreas, kidneys, stomach, and gallbladder—all organs involved in digestion and elimination of waste. So, before taking a Mounjaro injection, you consult with a professional and get it from a reputed chemist store in Houston

Do you really want Mounjaro for weight loss or type 2 diabetes? 

Mounjaro injection isn’t the solution if you’re trying to drop 10 pounds quickly in order to get in shape for a vacation. However, it’s worthwhile to speak with a healthcare professional, such as your primary care physician or an obesity specialist, if you have diabetes or are obese. In addition to the medication, your doctor probably will suggest diet and exercise to get effective results.

In summary

Mounjaro and Ozempic are once-weekly injections for adults with Type 2 diabetes. They both function similarly, but Mounjaro has the potential to produce more weight loss and a higher A1C reduction. 

Additionally, the diabetes medication for weight loss, tirzepatide has demonstrated remarkable efficacy in treating weight loss in the most recent clinical trials. Mounjaro proved to be more successful than Ozempic, with patients losing 26.6% of their body weight over 84 weeks. By increasing satiety, breaking down fat, and lowering sugar cravings, the medication aids in weight loss.

If you’re debating whether Mounjaro or Ozempic is right for you, consult with your doctor. They might help in balancing the benefits and drawbacks of each to determine which is the best fit. And, get it from the reputed community pharmacy only. If you are looking for one in Houston, reach out to the Scott Read Pharmacy – the leading drugstore in Houston

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>